Prevalence ratios (95% confidence intervals) for request of <i>EGFR</i> mutation testing by patient characteristics.

*<p>Multivariate analysis included 1,315 patients, and adjusted for gender, age at diagnosis, smoking status, mobility at admission, disease stage, tumor histology, and period of admission.